Skip to main content
. 2017 Jan 5;12(1):e0169559. doi: 10.1371/journal.pone.0169559

Fig 3. Distribution of different user groups in the respective treatment settings.

Fig 3

Severe (n = 99), moderate I (n = 88), moderate II (n = 83), at risk (n = 97)